Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3707795012 | Product containing tobramycin in ocular dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3707796013 | Tobramycin-containing product in ocular dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tobramycin-containing product in ocular dose form | Is a | Product manufactured as ocular dose form | true | Inferred relationship | Some | ||
| Tobramycin-containing product in ocular dose form | Is a | Tobramycin-containing product | true | Inferred relationship | Some | ||
| Tobramycin-containing product in ocular dose form | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Some | ||
| Tobramycin-containing product in ocular dose form | Has active ingredient | Tobramycin | true | Inferred relationship | Some | 1 | |
| Tobramycin-containing product in ocular dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dexamethasone- and tobramycin-containing product in ocular dose form | Is a | True | Tobramycin-containing product in ocular dose form | Inferred relationship | Some | |
| Tobramycin only product in ocular dose form | Is a | True | Tobramycin-containing product in ocular dose form | Inferred relationship | Some | |
| Loteprednol- and tobramycin-containing product in ocular dose form | Is a | True | Tobramycin-containing product in ocular dose form | Inferred relationship | Some | |
| Fluorometholone- and tobramycin-containing product in ocular dose form | Is a | True | Tobramycin-containing product in ocular dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR